 Randall Wilkening
Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 68 | 2024 | 856 | 1.290 |
Why?
| | Fetus | 35 | 2024 | 806 | 1.200 |
Why?
| | Placenta | 40 | 2023 | 750 | 1.190 |
Why?
| | Fetal Growth Retardation | 18 | 2024 | 565 | 0.890 |
Why?
| | Liver | 16 | 2024 | 1943 | 0.710 |
Why?
| | Uterus | 19 | 2020 | 215 | 0.640 |
Why?
| | Glucose | 16 | 2024 | 1020 | 0.640 |
Why?
| | Amino Acids | 13 | 2023 | 497 | 0.620 |
Why?
| | Oxygen Consumption | 18 | 2024 | 696 | 0.610 |
Why?
| | Maternal-Fetal Exchange | 18 | 2013 | 165 | 0.570 |
Why?
| | Oxygen | 16 | 2023 | 931 | 0.500 |
Why?
| | Placental Insufficiency | 7 | 2023 | 116 | 0.470 |
Why?
| | Pregnancy | 61 | 2024 | 6763 | 0.470 |
Why?
| | Fetal Blood | 20 | 2014 | 327 | 0.450 |
Why?
| | Umbilical Veins | 11 | 2002 | 62 | 0.410 |
Why?
| | Fetal Hypoxia | 4 | 2017 | 54 | 0.390 |
Why?
| | Glucagon | 4 | 2016 | 109 | 0.370 |
Why?
| | Pregnancy, Animal | 7 | 2006 | 52 | 0.360 |
Why?
| | Umbilical Cord | 10 | 2016 | 85 | 0.330 |
Why?
| | Hindlimb | 6 | 2017 | 128 | 0.310 |
Why?
| | Umbilical Arteries | 7 | 2005 | 55 | 0.290 |
Why?
| | Animals | 72 | 2024 | 36940 | 0.270 |
Why?
| | Pulmonary Circulation | 7 | 1991 | 429 | 0.240 |
Why?
| | Gluconeogenesis | 5 | 2024 | 79 | 0.240 |
Why?
| | Lactic Acid | 12 | 2024 | 305 | 0.240 |
Why?
| | Regional Blood Flow | 17 | 2005 | 474 | 0.230 |
Why?
| | Acidosis | 2 | 2020 | 101 | 0.220 |
Why?
| | Hypoxia | 4 | 2016 | 1112 | 0.200 |
Why?
| | Gestational Age | 14 | 2006 | 910 | 0.190 |
Why?
| | Blood Glucose | 14 | 2014 | 2186 | 0.190 |
Why?
| | Somatostatin | 1 | 2002 | 61 | 0.190 |
Why?
| | RNA, Messenger | 5 | 2016 | 2833 | 0.180 |
Why?
| | Oxidation-Reduction | 3 | 2024 | 1060 | 0.180 |
Why?
| | Glutamine | 5 | 2023 | 103 | 0.170 |
Why?
| | Ethanol | 6 | 2004 | 608 | 0.170 |
Why?
| | Insulin | 9 | 2017 | 2409 | 0.170 |
Why?
| | Organ Size | 12 | 2016 | 477 | 0.170 |
Why?
| | Female | 67 | 2024 | 73304 | 0.170 |
Why?
| | Chorioamnionitis | 1 | 2020 | 42 | 0.160 |
Why?
| | Biological Transport | 11 | 2014 | 418 | 0.160 |
Why?
| | Protein Biosynthesis | 2 | 2017 | 433 | 0.160 |
Why?
| | Lactates | 6 | 1993 | 85 | 0.150 |
Why?
| | Disease Models, Animal | 7 | 2024 | 4295 | 0.150 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2016 | 32 | 0.150 |
Why?
| | Glutamic Acid | 6 | 2014 | 246 | 0.140 |
Why?
| | Vasodilation | 5 | 1991 | 499 | 0.140 |
Why?
| | Anemia | 2 | 2017 | 170 | 0.140 |
Why?
| | Umbilicus | 3 | 2013 | 18 | 0.140 |
Why?
| | Carbohydrate Metabolism | 2 | 2010 | 59 | 0.130 |
Why?
| | Threonine | 3 | 2003 | 47 | 0.130 |
Why?
| | Muscle Proteins | 1 | 2017 | 231 | 0.120 |
Why?
| | Alanine | 4 | 2002 | 152 | 0.110 |
Why?
| | Dexamethasone | 4 | 2003 | 368 | 0.110 |
Why?
| | Leucine | 4 | 2001 | 111 | 0.110 |
Why?
| | Muscle, Skeletal | 3 | 2017 | 1724 | 0.110 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 35 | 0.110 |
Why?
| | Blood Flow Velocity | 6 | 1999 | 413 | 0.110 |
Why?
| | Respiratory Therapy | 1 | 1993 | 23 | 0.110 |
Why?
| | Glycine | 3 | 2023 | 176 | 0.100 |
Why?
| | Antipyrine | 2 | 1984 | 3 | 0.100 |
Why?
| | Pancuronium | 2 | 1990 | 4 | 0.100 |
Why?
| | Pyruvic Acid | 2 | 2024 | 53 | 0.100 |
Why?
| | Hyperinsulinism | 1 | 1994 | 121 | 0.100 |
Why?
| | Histamine | 2 | 1990 | 67 | 0.100 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 1993 | 106 | 0.100 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2012 | 29 | 0.100 |
Why?
| | Streptococcus agalactiae | 1 | 1993 | 93 | 0.100 |
Why?
| | Macrophages | 1 | 2020 | 1547 | 0.100 |
Why?
| | Estrogen Receptor beta | 1 | 2012 | 40 | 0.100 |
Why?
| | Swimming | 1 | 2012 | 51 | 0.100 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 1993 | 137 | 0.100 |
Why?
| | Tryptophan Hydroxylase | 1 | 2012 | 53 | 0.090 |
Why?
| | Hydrocortisone | 4 | 2020 | 322 | 0.090 |
Why?
| | Up-Regulation | 1 | 2014 | 843 | 0.090 |
Why?
| | Raphe Nuclei | 1 | 2012 | 110 | 0.090 |
Why?
| | Streptococcal Infections | 1 | 1993 | 151 | 0.090 |
Why?
| | Acid-Base Equilibrium | 3 | 2003 | 28 | 0.090 |
Why?
| | Islets of Langerhans | 1 | 2017 | 803 | 0.080 |
Why?
| | Antidepressive Agents | 1 | 2012 | 236 | 0.080 |
Why?
| | Receptors, Histamine H1 | 1 | 1990 | 5 | 0.080 |
Why?
| | Carbohydrates | 1 | 2010 | 65 | 0.080 |
Why?
| | Receptors, Histamine H2 | 1 | 1990 | 8 | 0.080 |
Why?
| | Glycogen | 2 | 2016 | 55 | 0.080 |
Why?
| | Lysine | 2 | 2003 | 294 | 0.080 |
Why?
| | Hypoglycemia | 1 | 2014 | 445 | 0.080 |
Why?
| | Hot Temperature | 5 | 2001 | 391 | 0.080 |
Why?
| | Serine | 2 | 2023 | 141 | 0.080 |
Why?
| | Hepatocytes | 2 | 2024 | 220 | 0.080 |
Why?
| | Neuromuscular Junction | 1 | 1989 | 57 | 0.080 |
Why?
| | Diffusion | 4 | 1991 | 116 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2837 | 0.080 |
Why?
| | Nerve Block | 1 | 1989 | 73 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 1992 | 553 | 0.070 |
Why?
| | Hemoglobin A | 1 | 1988 | 21 | 0.070 |
Why?
| | Oxyhemoglobins | 1 | 1988 | 23 | 0.070 |
Why?
| | Nitric Oxide | 1 | 1993 | 915 | 0.070 |
Why?
| | Reference Values | 4 | 1997 | 816 | 0.070 |
Why?
| | Osmolar Concentration | 5 | 2004 | 171 | 0.070 |
Why?
| | Pelvis | 1 | 1988 | 102 | 0.070 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2006 | 319 | 0.070 |
Why?
| | Hemodynamics | 3 | 1991 | 1113 | 0.070 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2006 | 22 | 0.060 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2006 | 26 | 0.060 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2009 | 36 | 0.060 |
Why?
| | Polymers | 1 | 2010 | 490 | 0.060 |
Why?
| | Receptor, TIE-2 | 1 | 2005 | 12 | 0.060 |
Why?
| | Angiopoietin-1 | 1 | 2005 | 11 | 0.060 |
Why?
| | Glucocorticoids | 3 | 2001 | 594 | 0.060 |
Why?
| | Angiopoietin-2 | 1 | 2005 | 16 | 0.060 |
Why?
| | Vasodilator Agents | 1 | 1988 | 331 | 0.060 |
Why?
| | Hemoglobins | 1 | 1988 | 353 | 0.060 |
Why?
| | Microspheres | 3 | 1991 | 137 | 0.060 |
Why?
| | Pulmonary Artery | 2 | 1988 | 1086 | 0.060 |
Why?
| | Models, Biological | 6 | 2005 | 1783 | 0.060 |
Why?
| | Placental Circulation | 2 | 2006 | 71 | 0.060 |
Why?
| | Cycloleucine | 1 | 2004 | 4 | 0.060 |
Why?
| | Isoleucine | 2 | 2001 | 15 | 0.060 |
Why?
| | Valine | 2 | 2001 | 82 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2003 | 545 | 0.050 |
Why?
| | Glutamate Dehydrogenase | 1 | 2003 | 4 | 0.050 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2003 | 108 | 0.050 |
Why?
| | Blood Pressure | 6 | 2005 | 1786 | 0.050 |
Why?
| | Sugar Alcohols | 1 | 2002 | 3 | 0.050 |
Why?
| | Ornithine | 1 | 2002 | 26 | 0.050 |
Why?
| | Receptors, Growth Factor | 1 | 2002 | 55 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 64 | 0.050 |
Why?
| | Lymphokines | 1 | 2002 | 131 | 0.050 |
Why?
| | Veins | 3 | 2001 | 63 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2023 | 197 | 0.050 |
Why?
| | Liver Circulation | 2 | 2000 | 20 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2003 | 385 | 0.040 |
Why?
| | Labor, Induced | 2 | 2001 | 33 | 0.040 |
Why?
| | Histidine | 1 | 2001 | 64 | 0.040 |
Why?
| | Infant Care | 1 | 1981 | 45 | 0.040 |
Why?
| | Phenylalanine | 1 | 2001 | 68 | 0.040 |
Why?
| | Nitric Oxide Synthase | 1 | 2001 | 240 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1993 | 560 | 0.040 |
Why?
| | Labor, Obstetric | 1 | 2001 | 61 | 0.040 |
Why?
| | Arginine | 1 | 2002 | 271 | 0.040 |
Why?
| | Lung | 3 | 1988 | 4060 | 0.040 |
Why?
| | Methionine | 1 | 2001 | 160 | 0.040 |
Why?
| | Infant, Low Birth Weight | 1 | 1981 | 141 | 0.040 |
Why?
| | Placental Hormones | 1 | 1999 | 4 | 0.040 |
Why?
| | Norepinephrine | 1 | 2020 | 204 | 0.040 |
Why?
| | Tryptophan | 1 | 2001 | 183 | 0.040 |
Why?
| | Indocyanine Green | 1 | 1999 | 24 | 0.040 |
Why?
| | Kinetics | 4 | 2001 | 1670 | 0.040 |
Why?
| | Partial Pressure | 3 | 2006 | 30 | 0.040 |
Why?
| | Coloring Agents | 1 | 1999 | 87 | 0.040 |
Why?
| | Arteries | 3 | 2001 | 269 | 0.040 |
Why?
| | Infusions, Intravenous | 3 | 2003 | 413 | 0.030 |
Why?
| | Carbon Radioisotopes | 2 | 2014 | 34 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2012 | 2057 | 0.030 |
Why?
| | Carbon Dioxide | 4 | 1997 | 267 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2020 | 886 | 0.030 |
Why?
| | Glucose-6-Phosphatase | 1 | 2016 | 33 | 0.030 |
Why?
| | Body Temperature | 3 | 2006 | 222 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2003 | 976 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 1009 | 0.030 |
Why?
| | Hypertension | 1 | 2005 | 1295 | 0.030 |
Why?
| | Sheep, Domestic | 1 | 2014 | 34 | 0.030 |
Why?
| | Infant, Newborn | 4 | 1995 | 6079 | 0.030 |
Why?
| | Glutamates | 1 | 1994 | 59 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 657 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 828 | 0.030 |
Why?
| | DNA, Complementary | 2 | 2005 | 272 | 0.030 |
Why?
| | Embryonic and Fetal Development | 3 | 2001 | 97 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1738 | 0.030 |
Why?
| | Bicarbonates | 1 | 1993 | 44 | 0.020 |
Why?
| | Body Weight | 2 | 1997 | 985 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2012 | 316 | 0.020 |
Why?
| | Time Factors | 2 | 1993 | 6828 | 0.020 |
Why?
| | Humans | 11 | 2023 | 137585 | 0.020 |
Why?
| | Guinea Pigs | 1 | 1992 | 158 | 0.020 |
Why?
| | Cats | 1 | 1992 | 210 | 0.020 |
Why?
| | Horses | 1 | 1992 | 111 | 0.020 |
Why?
| | Constriction | 1 | 1991 | 47 | 0.020 |
Why?
| | Plasmids | 1 | 2012 | 363 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2012 | 138 | 0.020 |
Why?
| | Receptors, Androgen | 1 | 2012 | 150 | 0.020 |
Why?
| | Biological Transport, Active | 2 | 2005 | 77 | 0.020 |
Why?
| | Estrogen Receptor alpha | 1 | 2012 | 145 | 0.020 |
Why?
| | Platelet Activating Factor | 1 | 1991 | 76 | 0.020 |
Why?
| | Heart Rate | 3 | 1990 | 822 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2607 | 0.020 |
Why?
| | Myo-Inositol-1-Phosphate Synthase | 1 | 2010 | 2 | 0.020 |
Why?
| | Fever | 2 | 2003 | 306 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1793 | 0.020 |
Why?
| | Mannose | 1 | 2010 | 24 | 0.020 |
Why?
| | Sorbitol | 1 | 2010 | 14 | 0.020 |
Why?
| | Neurogenesis | 1 | 2012 | 149 | 0.020 |
Why?
| | Inositol | 1 | 2010 | 26 | 0.020 |
Why?
| | Rabbits | 1 | 1992 | 794 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2012 | 378 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 350 | 0.020 |
Why?
| | Vascular Resistance | 2 | 1988 | 375 | 0.020 |
Why?
| | Histamine H1 Antagonists | 1 | 1990 | 30 | 0.020 |
Why?
| | Fructose | 1 | 2010 | 112 | 0.020 |
Why?
| | Histamine H2 Antagonists | 1 | 1990 | 30 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2531 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 26 | 0.020 |
Why?
| | Aorta, Abdominal | 1 | 1989 | 46 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 44 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 1993 | 645 | 0.020 |
Why?
| | Mathematics | 2 | 1996 | 103 | 0.020 |
Why?
| | Iliac Vein | 1 | 1988 | 13 | 0.020 |
Why?
| | Bradykinin | 1 | 1988 | 46 | 0.020 |
Why?
| | Iliac Artery | 1 | 1988 | 55 | 0.020 |
Why?
| | Acetylcholine | 1 | 1988 | 185 | 0.020 |
Why?
| | Tolazoline | 1 | 1986 | 2 | 0.020 |
Why?
| | Muscles | 1 | 1988 | 326 | 0.020 |
Why?
| | Algorithms | 1 | 2014 | 1704 | 0.020 |
Why?
| | Hippocampus | 1 | 2012 | 895 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2486 | 0.020 |
Why?
| | Heating | 1 | 2006 | 23 | 0.020 |
Why?
| | Placentation | 1 | 2005 | 45 | 0.020 |
Why?
| | Respiration | 1 | 2006 | 199 | 0.020 |
Why?
| | DNA | 1 | 2012 | 1459 | 0.010 |
Why?
| | Bone and Bones | 1 | 1988 | 317 | 0.010 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2005 | 32 | 0.010 |
Why?
| | Pulsatile Flow | 1 | 2005 | 60 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2012 | 2475 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 3412 | 0.010 |
Why?
| | Decarboxylation | 2 | 1994 | 3 | 0.010 |
Why?
| | 2-Aminoadipic Acid | 1 | 2003 | 8 | 0.010 |
Why?
| | Amino Acids, Essential | 1 | 2003 | 13 | 0.010 |
Why?
| | Metabolic Clearance Rate | 1 | 2003 | 115 | 0.010 |
Why?
| | Signal Transduction | 2 | 2009 | 5079 | 0.010 |
Why?
| | Nuclease Protection Assays | 1 | 2003 | 4 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5647 | 0.010 |
Why?
| | Drinking | 1 | 2003 | 42 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2003 | 201 | 0.010 |
Why?
| | Skin | 1 | 1988 | 752 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 86 | 0.010 |
Why?
| | Length of Stay | 1 | 1989 | 1215 | 0.010 |
Why?
| | Enzyme Induction | 1 | 2003 | 90 | 0.010 |
Why?
| | Respiratory Mechanics | 1 | 2003 | 67 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 155 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 71 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 79 | 0.010 |
Why?
| | Birth Weight | 2 | 1999 | 516 | 0.010 |
Why?
| | Male | 3 | 2017 | 67762 | 0.010 |
Why?
| | Species Specificity | 1 | 2002 | 585 | 0.010 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2001 | 204 | 0.010 |
Why?
| | Homeostasis | 1 | 1984 | 621 | 0.010 |
Why?
| | Fetal Weight | 1 | 2000 | 56 | 0.010 |
Why?
| | Placental Lactogen | 1 | 1999 | 23 | 0.010 |
Why?
| | Carbon Isotopes | 1 | 2000 | 144 | 0.010 |
Why?
| | Prolactin | 1 | 1999 | 96 | 0.010 |
Why?
| | Base Sequence | 1 | 2003 | 2181 | 0.010 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 1981 | 146 | 0.010 |
Why?
| | Blotting, Western | 1 | 2001 | 1226 | 0.010 |
Why?
| | Prenatal Care | 1 | 1981 | 294 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2003 | 2900 | 0.010 |
Why?
| | Progesterone | 1 | 1999 | 254 | 0.010 |
Why?
| | Phentolamine | 2 | 1987 | 15 | 0.010 |
Why?
| | Trophoblasts | 1 | 1999 | 199 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 1997 | 91 | 0.010 |
Why?
| | Keto Acids | 1 | 1996 | 13 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2002 | 1164 | 0.010 |
Why?
| | Linear Models | 1 | 1997 | 849 | 0.010 |
Why?
| | Regression Analysis | 1 | 1996 | 1024 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1995 | 844 | 0.010 |
Why?
| | Phospholipid Ethers | 1 | 1991 | 7 | 0.010 |
Why?
| | Meclofenamic Acid | 1 | 1991 | 10 | 0.010 |
Why?
| | Medical Indigency | 1 | 1989 | 11 | 0.000 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 1987 | 36 | 0.000 |
Why?
| | Infant, Newborn, Diseases | 1 | 1989 | 113 | 0.000 |
Why?
| | Cimetidine | 1 | 1986 | 13 | 0.000 |
Why?
| | Humidity | 1 | 1987 | 50 | 0.000 |
Why?
| | Verapamil | 1 | 1986 | 41 | 0.000 |
Why?
| | Diphenhydramine | 1 | 1986 | 37 | 0.000 |
Why?
| | Perfusion | 1 | 1987 | 213 | 0.000 |
Why?
| | Fetal Heart | 1 | 1986 | 55 | 0.000 |
Why?
| | Ambulatory Care | 1 | 1989 | 546 | 0.000 |
Why?
| | Tritium | 1 | 1983 | 76 | 0.000 |
Why?
| | Adult | 2 | 2002 | 37929 | 0.000 |
Why?
| | Patient Readmission | 1 | 1989 | 697 | 0.000 |
Why?
| | Organ Specificity | 1 | 1983 | 305 | 0.000 |
Why?
| | Patient Discharge | 1 | 1989 | 897 | 0.000 |
Why?
| | Fasting | 1 | 1983 | 281 | 0.000 |
Why?
|
|
Wilkening's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|